Kristina Lend
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Flare risk after oral glucocorticoid bridging with methotrexate or intra-articular bridging with triple therapy in early rheumatoid arthritis.
Journal: Journal of internal medicine
Published: April 07, 2026
Hand-dominant joint involvement pattern associates with favourable, and polyarthritis with unfavourable, treatment response to both csDMARDs and bDMARDs in early rheumatoid arthritis: a combined analysis of NORD-STAR and BeSt trials.
Journal: Annals of the rheumatic diseases
Published: October 28, 2025
Hand-dominant joint involvement pattern associates with favourable, and polyarthritis with unfavourable, treatment response to both csDMARDs and bDMARDs in early rheumatoid arthritis: a combined analysis of NORD-STAR and BeSt trials.
Journal: Annals of the rheumatic diseases
Published: October 28, 2025
Certolizumab pegol, abatacept, tocilizumab or active conventional therapy in early rheumatoid arthritis: 48-week patient-reported outcomes from the NORD-STAR trial.
Journal: The Lancet. Rheumatology
Published: October 02, 2025
Correction: Disease activity and treatment response in early rheumatoid arthritis: an exploratory metabolomic profiling in the NORD-STAR cohort.
Journal: Arthritis research & therapy
Published: September 26, 2025
Acylcarnitine enrichment as a characteristic of rheumatoid arthritis fibroblast-like synoviocyte metabolic fingerprint.
Journal: Journal of translational autoimmunity
Published: May 02, 2025
Disease activity and treatment response in early rheumatoid arthritis: an exploratory metabolomic profiling in the NORD-STAR cohort.
Journal: Arthritis research & therapy
Published: April 01, 2025
Association of Soluble Immune Checkpoint Molecules PD1 and 4-1BB With CTLA-4Ig Treatment Response in Early Rheumatoid Arthritis.
Journal: ACR open rheumatology
Published: February 28, 2025
Treatment with methotrexate plus oral prednisolone versus triple therapy (methotrexate/sulfasalazine/hydroxychloroquine) plus intra-articular glucocorticoids in early rheumatoid arthritis: a prespecified nonrandomised subgroup analysis of clinical and radiographic data at 48 weeks from the NORD-STAR trial's conventional treatment arm.
Journal: Annals of the rheumatic diseases
Published: February 25, 2025
Epitopes targeted by autoantibodies in presymptomatic individuals predict early rheumatoid arthritis.
Journal: Annals of the rheumatic diseases
Published: December 20, 2024
Glucocorticoid treatment in early rheumatoid arthritis is independently associated with increased PCSK9 levels: data from a randomised controlled trial.
Journal: RMD open
Published: October 14, 2024
Last Updated: 09/26/2026